The utility of oral diabetes medications in type 2 diabetes of the young.

The utility of oral diabetes medications in type 2 diabetes of the young. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The utility of oral diabetes medications in type 2 diabetes of the young. Abstract Text:

Michael P Kane,Asim Abu-Baker,Robert S Busch,

Background: An estimated two-thirds of medications prescribed for use in pediatric patients have not been proven safe or effective for this patient population. Since 1995 a dozen orally administered diabetes medications or combination of medications for the management of type 2 diabetes mellitus have been approved by the Food and Drug Administration. Of these, only one (metformin) is approved for use in pediatrics. As the prevalence of children diagnosed with type 2 diabetes continues to rise, the need for adequate information regarding the safety, efficacy, and appropriate dosing of oral diabetes medications in the pediatric population likewise increases. Objective: The purpose of this paper is to present the data available regarding the use of oral diabetes medications in a pediatric type 2 diabetes population. Methods: A computerized literature search was performed using Medline and the Cochrane Database of Systematic Reviews. Results: The Table consists of a summary of data regarding the use of oral antidiabetic agents in pediatric patients. These data include information regarding drug safety and efficacy and/or drug pharmacokinetic and drug dosing information. Conclusions: Data concerning the safety and efficacy of oral diabetes medications to treat type 2 diabetes of the young is limited. Data currently available support the use of metformin as first-line drug therapy. Results of prospective studies over the next three to five years will better define the role of thiazolidinedione use as initial therapy in pediatric type 2 diabetes patients.

The utility of oral diabetes medications in type 2 diabetes of the young. Publishing Authors By Initials

MP Kane,A Abu-Baker,RS Busch,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The utility of oral diabetes medications in type 2 diabetes of the young. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current diabetes reviews

VOLUME: 1

Page Numbers: 83-92

Journal Abbreviation:

ISSN: 1573-3998

DAY: 28

MONTH: Feb

YEAR: 2005

The utility of oral diabetes medications in type 2 diabetes of the young. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101253260

The utility of oral diabetes medications in type 2 diabetes of the young. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The utility of oral diabetes medications in type 2 diabetes of the young. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The utility of oral diabetes medications in type 2 diabetes of the young.

AFFILIATION: Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208, USA. kanem@acp.edu.

Country: United Arab Emirates

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Diabetes Rev

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The utility of oral diabetes medications in type 2 diabetes of the young Related Publications

• Antibodies to a novel antigen in acute hepatitis C virus infections.
• Defining correlates of T cell protection against infection.
• Determination of the enantiomeric composition of guest molecules by chemometric analysis of the UV-visible spectra of cyclodextrin guest-host complexes.
• Do state parity laws reduce the financial burden on families of children with mental health care needs?
• Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.
• Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms.
• Improving survival in acute lung injury: is there a role for treatment bundles?
• Inhalation of the ETA receptor antagonist LU-135252 selectively attenuates hypoxic pulmonary vasoconstriction.
• Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients.
• Local physiological changes during photodynamic therapy.
• Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
• Olefin oxygenation by the hydroperoxide adduct of a nonheme manganese(IV) complex: epoxidations by a metallo-peracid produces gentle selective oxidations.
• One target-multiple indications: a call for an integrated common mechanisms strategy.
• Origin of CD8+ Effector and Memory T Cell Subsets.
• Persistence of West Nile virus-specific antibodies in viremic blood donors.
• Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.
• Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
• Reply.
• Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates.
• The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.
• The neuronal dynamics underlying cognitive flexibility in set shifting tasks.
• The utility of oral diabetes medications in type 2 diabetes of the young.
• Transfusion-associated microchimerism.
• Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients.
• Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
• [Female genital actinomycosis]
• [In Process Citation]
• [Prediction of spontaneous abortion by vaginal cytologic smears (author's transl)i1]
• [Problems of corticoid therapy in pregnancy]
• [The effects of metacresol sulfonic acid on defects and inflammations of the genital mucosa.]